Being overweight and obese: Black children ages 2-5 years

Cindy E Hudson1

  • 1University of Pennsylvania, School of Nursing, Center for Health Disparities Research, PA, USA. chudson@nursing.upenn.edu

Insights

Childhood obesity is a major health issue, particularly affecting Black children by age six. Early interventions targeting lifestyle behaviors in young Black children and their families are crucial for preventing long-term health disparities.

Area of Science:

  • Pediatric Public Health
  • Childhood Obesity Research
  • Health Disparities

Background:

  • Childhood obesity presents a significant public health challenge with long-term medical and economic consequences.
  • While obesity prevalence is similar in white and Black preschoolers, Black children experience higher rates by age six.
  • Numerous factors contribute to childhood obesity, including diet, physical activity, cultural influences, environment, and parental perceptions.

Purpose of the Study:

  • To highlight the escalating prevalence of obesity in Black children by age six.
  • To underscore the importance of addressing lifestyle behaviors and environmental factors contributing to childhood obesity.
  • To advocate for targeted interventions and culturally appropriate strategies to combat childhood obesity and reduce health disparities.

Main Methods:

  • Review of existing literature on childhood obesity prevalence and risk factors.
  • Analysis of demographic data concerning obesity rates in preschool-aged children.
  • Synthesis of factors associated with obesity, including behavioral, cultural, and environmental influences.

Main Results:

  • Obesity prevalence in Black preschoolers is slightly higher than in white preschoolers.
  • By age six, Black children exhibit a higher prevalence of obesity compared to white children.
  • Lifestyle behaviors, cultural context, environment, and parental perceptions are key factors associated with preschool obesity.

Conclusions:

  • Targeted programs for young Black children and their families are essential for obesity prevention.
  • Promoting healthy behaviors can help eliminate health disparities and improve quality of life.
  • Nurses play a vital role in implementing culturally sensitive strategies at community and family levels to prevent childhood overweight and obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...